IPG
39
-3
MDLZ
65
-2
EXPD
53
-3
TGNA
48
-2
C
60
-2
AMG
41
-3
CNX
80
4
PNW
66
3
FTI
82
4
BAX
30
-3
SLB
53
-3
NVDA
52
-3
LNC
52
2
SWKS
38
-2
ADI
59
-2
FRT
36
-2
HRL
30
-5
UAL
56
2
WFC
63
3
TROW
34
-5
IPG
39
-3
MDLZ
65
-2
EXPD
53
-3
TGNA
48
-2
C
60
-2
AMG
41
-3
CNX
80
4
PNW
66
3
FTI
82
4
BAX
30
-3
SLB
53
-3
NVDA
52
-3
LNC
52
2
SWKS
38
-2
ADI
59
-2
FRT
36
-2
HRL
30
-5
UAL
56
2
WFC
63
3
TROW
34
-5
Financhill
Back

CI Global Investment Grade ETF C$ Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
36

CGIN.TO
CI Global Investment Grade ETF C$

Last Price:
21.64
Seasonality Move:
3.68%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
36
CI Global Investment Grade ETF C$ (CGIN.TO) is a Sell

Is CI Global Investment Grade ETF C$ a Buy, Sell or Hold?

  • The current CI Global Investment Grade ETF C$ [CGIN.TO] share price is $21.64. The Score for CGIN.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CGIN.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CGIN.TO Stock Price Chart

What is CI Global Investment Grade ETF C$'s stock price today?

  • The CI Global Investment Grade ETF C$ share price today is $21.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGIN.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CGIN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 65.65 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.38 - 21.6) Buy
Bollinger Bands (100): (20.62 - 21.36) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CGIN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.63 Buy
20-day SMA: 21.52 Buy
50-day SMA: 21.3 Buy
200-day SMA: 20.77 Buy
8-day EMA: 21.61 Buy
20-day EMA: 21.52 Buy
50-day EMA: 21.32 Buy
200-day EMA: 20.82 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

CI Global Investment Grade ETF C$ Earnings Growth & CGIN.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

CI Global Investment Grade ETF C$ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):